Our Team

Board of Directors

Tony H NounTony H Noun
Director/Executive Chairman


Tony has more than 20 years professional and commercial experience with a proven track record of success. Currently, he is not only the Chairman of the Northern Cancer Institute group, but also a public company and a substantive number of other private companies that include, an Australian Financial Services License holder and specialist Healthcare Management Consultancy Practice.

Tony's commercial experience, from both an investor and manager perspective, spans a diverse range of disciplines and thus, brings extensive healthcare, financial and corporate experience to lead the Board and Management of Northern Cancer Institute to provide its patients with Excellence in Care.

Damien WilliamsDamien Williams
Alternate Director to Tony Noun

Damien has been a member of the Cancer Care Associates Group for over 20 years, is the Managing Director for the Riverina Cancer Care Centre (a comprehensive cancer care facility providing amongst other services, radiation and medical oncology, to both private and public sector patients, in a regional area), and holds a Diploma of Applied Science (Medical Radiation Technology) as well as an MBA. Additionally, he is a board member of the NSW Cancer Council, South West Region Advisory Council, and a committee member of the NSW Cancer Institute, Rural Oncology Group. This not only gives him a unique perspective into healthcare management, but enables him to be well-positioned to lead the Radiation Oncology team.

Richard RyanRichard Ryan

Richard has over 20 years’ experience in the healthcare industry having worked in both public and private hospitals. Commencing his career as a  Registered Nurse in the field of cardiology and cardiothoracic surgery. Richard joined North Shore Private Hospital in April 2005 as Nursing Unit Manager of Cardiology and Cardiothoracic Ward and Assistant Director of Clinical Services before moving to Kareena Private Hospital and more recently St George Private Hospital as the Director of Clinical Services. Richard was also responsible for the clinical services bid for Northern Beaches Private Hospital. He returned to North Shore Private Hospital in April 2015 as the Deputy Chief Executive Officer and was appointed to the position of Chief Executive Officer in April 2016.

Assoc Professor Nick PavlakisNick Pavlakis
Director, Assoc Prof

A/Prof Nick Pavlakis underwent undergraduate medical training at the University of NSW and graduated in 1991. He underwent general medical training and subsequent advanced training in Medical Oncology at Royal North Shore Hospital, completing FRACP in 1997. He then spent 3 years completing a PhD in new cancer drug development involving an Australian developed anti-angiogenic compound PI-88 (Progen Industries and ANU); and a Masters of Clinical Epidemiology through the University of Sydney. He has worked in private oncology practice since 1998 and has been a practice member of the Northern Cancer Institute since 2001. He is current Chair of the Lung Cancer Group of the Clinical Oncologic Society for Australa (COSA), and is Regent for Australasia for the International Association for the Study of Lung Cancer (IASLC).

He is an academic medical oncologist, having published journal manuscripts in his interest areas (lung cancer, mesothelioma, NETS, kidney cancer, gastric cancer, colorectal cancer and bisphosphonate therapy, is conducting ongoing collaboratve clinical research ((Australasian Gastro-intestinal Trials Group (AGITG), ALTG,  Australia and NZ Urologic and Prostate Cancer Trials Group (ANZUP)) and translational research with the Bill Walsh Cancer Research Laboratories/Kolling Institute.

Dominic MayDominic May

Dominic May is a Commercial Manager at North Shore Private Hospital St Leonards and is a member of the hospital Executive Team. His primary responsibility is to oversee the commercial obligations at North Shore Private Hospital and to contribute to the efficient and professional performance of the hospital through his contribution as a member of the hospital Executive Team.

He has attained a Master of Management through the Macquarie University Graduate School of Management - MGSM.

Dominic has over 30 years commercial management experience in industries including Private Health Care, Medical & Scientific Research, International Trade Finance, Corporate & Commercial Banking & the Australian Wine Industry.

Professor Stephen ClarkeStephen Clarke

Stephen Clarke is a medical oncologist, pharmacologist and translational researcher with major clinical and research interests in gastrointestinal and thoracic cancers and pharmacology. He is a medical oncologist at the Northern Cancer Institute and Royal North Shore Hospital, Director of Cancer Services at Northern Sydney Local Health District and Professor of Medicine at the University of Sydney.

Prof Clarke completed his medical degree at the University of Sydney in 1983 and an FRACP in Medical Oncology at Royal North Shore Hospital in 1990. He then completed a PhD at the University of London at the Institute of Cancer Research / Royal Marsden Cancer Hospital. Professor Clarke returned from the UK in 1994 and has worked at Westmead, Nepean, Concord and Royal Prince Alfred Hospitals prior to returning to Royal North Shore Hospital in 2010. He obtained an MD from the University of Sydney in 2011.

Stephen was awarded an OAM in the Australia Day Honours in 2011 for services to medicine in the disciplines of oncology and pharmacology. He was also awarded the Eric Susman Prize from the Royal Australasian College of Physicians in 2013. In 2015 he was elected to the newly created Australian Academy of Health and Medical Science. He was also elected to be an inaugural member of Best Doctors in Australia and New Zealand in 2012.

Stephen is Head of the NSW committee of the RACP and is Oncology Advisor to the Department of Veterans Affairs as well as a Member of the Repatriation Pharmaceutical Review Committee. He has received over $25 million in competitive research funding, which has produced over 260 publications, leading to more than 10000 citations.

Dr Connie Diakos Connie Diakos
Alternate Director to Stephen Clarke

Dr Connie Diakos is a medical oncologist specialising in gastrointestinal, breast and gynaecological cancers. She holds a PhD in platinum anti-cancer drug mechanism of action from the University of Sydney, and is an active researcher investigating the causes and consequences of inflammation in cancer in the Bill Walsh Translational Cancer Research Laboratory at the Kolling Institute of the University of Sydney.

Dr Diakos completed an FRACP in Medical Oncology in the Royal Prince Alfred Hospital network. She is a Staff Specialist at Royal North Shore Hospital and holds admitting rights to North Shore Private Hospital and actively participates in the multidisciplinary teams at Royal North Shore Hospital in her specialist tumour groups. She is involved in teaching of medical students, junior medical officers and physician trainees at Royal North Shore Hospital, and the supervision of research students at the University of Sydney.

Sally Baron-HaySally Baron-Hay
Alternate Director to Nick Pavlakis

Dr Baron-Hay is physician whose main area of interest is in the management of patients diagnosed with breast and gynaecological malignancies.

She participates in the Multidisciplinary care of theses malignancies attending weekly multidisciplinary meetings. These meetings are attending also by radiologists, pathologists, surgeons, radiotherapists, clinical nurse specialists and allied health care professionals.

Her laboratory research interests are discovering new biomarkers of ovarian cancer and their prognostic significance. She also actively participates in clinical trials in breast and gynaecological malignancies. These trials involve the use of new drugs investigating activity in these malignancies as well as trials designed to improve the quality of life of patients. She is actively involved in teaching, both medical students and allied health professional. 

Dr Baron-Hay has admitting rights to North Shore Private Hospital and administers chemotherapy treatments through the Northern Cancer Institute at the hospital.